An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation

Molecular Cancer Research

Volumn 4, Issue 7, 2006, Pages 481-488

  Cerchia, Laura ^a   D'Alessio, Amelia ^b   Amabile, Giovanni ^a   Duconge, Frederic ^c   Pestourie, Carine ^c   Tavitian, Bertrand ^c   Libri, Domenico ^d   De Franciscis, Vittorio ^a  

^a CNR   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c DIF   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIC FACTOR; PROTEIN RET; PROTEIN TYROSINE KINASE; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DIMERIZATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MICE; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-RET; TRETINOIN;

EID: 33746895147     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0050     Document Type: Article

References (37)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
2. Reynolds CP, Schindler PF, Jones DM, Gentile JL, Proffitt RT, Einhorn PA. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines. Prog Clin Biol Res 1994;385:237-44.
3. Melino G, Thiele CJ, Knight RA, Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol 1997;31: 65-83.
4. Reynolds CP, Kane DJ, Einhorn PA, et al. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 1991;366:203-11.
5. Matthay KK, Villabianca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
6. Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 2003;197:185-92.
7. Manie S, Santoro M, Fusco A, Billaud M. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet 2001;17: 580-9.
8. Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002;3:383-94.
9. Baloh RH, Enomoto H, Johnson EM, Milbrandt J. The GDNF family ligands and receptors implications for neural development. Curr Opin Neurobiol 2000;10: 103-10.
10. Borrello MG, Bongarzone I, Pienotti MA, et al. Trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of Trk expression in non-advanced stages. Int J Cancer 1993;54:540-5.
11. Perri P, Longo L, McConville C, et al. Linkage analysis in families with recurrent neuroblastoma. Ann N Y Acad Sci 2002;963:74-84.
12. Hishiki T, Nimura Y, Isogai E, et al. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret. GFRα-1, and GFRα-2. Cancer Res 1998;58:2158-65.
13. McConville CM, Forsyth J. Neuroblastoma-a developmental perspective. Cancer Lett 2003;197:3-9.
14. Bunone G, Borrello MG, Ricetti R, et al. Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp Cell Res 1995;217:92-9.
15. D'Alessio A, De Vita G, Cali G, et al. Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. Cell Growth Differ 1995;11:1387-94.
16. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 1993;11:321-31.
17. Cerchia L, Libri D, Carlomagno MS, de Franciscis V. The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret. Biochem J 2003;372:897-903.
18. Amoresano A, Incoronato M, Monti G, Pucci P, de Franciscis V, Cerchia L. Direct interactions among Ret, GDNF and the GFRα1 molecules reveal new insights into the assembly of a functional three-protein complex. Cell Signal 2005;17:717-27.
19. Cerchia L, Duconge F, Pestourie C, et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 2005;3:e123.
20. Tsui-Pierchala BA, Milbrandt J, Johnson EM, Jr. NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 2002;33:261-73.
21. Colucci-D'Amato GL, D'Alessio A, Califano D, et al. Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK. J Biol Chem 2000;275: 19306-14.
22. Xiao H, Hirata Y, Isobe K, Kiuchi K. Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. J Neurochem 2002;82:801-8.
23. Peterson S, Bogenmann E. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation. Oncogene 2004;23:213-25.
24. Rossi A, Granata F, Augusti-Tocco G, Canu N, Levi A, Possenti R. Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein. Int J Dev Neurosci 1992;10:527-34.
25. Dimitroulakos J, Squire J, Pawlin G, Yeger H. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages. Cell Growth Differ 1994;5:373-84.
26. Olsson AK, Nanberg E. A functional role for ERK in gene induction, but not in neurite outgrowth in differentiating neuroblastoma cells. Exp Cell Res 2001; 265:21-30.
27. Tucholski J, Lesort M, Johnson GV. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 2001; 102:481-91.
28. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic-acid induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 2003;278:391-9.
29. Hansford LM, Marshall GM. Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation. Neurosci Lett 2005;389:77-82.
30. Melino G, Annicchiarico-Petruzzelli M, Piredda L, et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994;14:6584-96.
31. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-7.
32. Johnson GV, Cox TM, Lockhart JP, Zinnerman MD, Miller ML, Powers RE. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res 1997;751:323-9.
33. Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 1993;120:1461-70.
34. Feng JF, Rhce SG, Im MJ. Evidence that phospholipase δ1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem 1996;271: 16451-4.
35. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 1992;52:271-8.
36. Miloso M, Villa D, Crimi M, et al. Retinoic acid-induced neuritogencsis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res 2004;75:241-52.
37. Peluso G, Petillo O, Barbarisi A, et al. Camitine protects the molecular chaperone activity of lens α-crystallin and decreases the posttranslational protein modifications induced by oxidative stress. FASEB J 2001;15:1604-6.